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Abstract 41 
The fungal pathogen Batrachochytrium dendrobatidis has caused declines and extinctions in hundreds 42 
of amphibian species across the world. Virulence varies among and within lineages; the Global 43 
Panzootic Lineage (GPL) is the most pathogenic, although there is also variation in lethality between 44 
GPL isolates. Amphibians have a number of defences against pathogens, and skin products including 45 
the microbiota and host peptides have been shown to have considerable influence over disease 46 
progression. Here we show the collective skin products (the mucosome) of two amphibian species 47 
show significant variation in their ability to inhibit different globally-distributed isolates of GPL. This 48 
may in part explain the variation in disease susceptibility of hosts to different strains of 49 
Batrachochytrium dendrobatidis. More work is required to identify particular traits associated with 50 
mucosomes that confer broad-spectrum inhibition across GPL in order to facilitate the development of 51 
prophylaxis and/or treatments for chytridiomycosis in situ.  52 
 53 
 54 
  55 
 3 
Main article 56 
Although there are a number of emerging infectious diseases that are devastating wildlife populations 57 
globally, chytridiomycosis is unique in its ability to infect amphibian hosts across an unprecedented 58 
diversity of genera and species within a given class of vertebrates [1]. This disease has been linked to 59 
the decline and extinction of hundreds of amphibian species worldwide, and it is the most devastating 60 
wildlife disease of vertebrates in recorded history [1]. Amphibian chytridiomycosis is caused by fungal 61 
Chytridiomycetes of the genus Batrachochytrium, of which two have been identified to date; B. 62 
dendrobatidis and B. salamandrivorans [2,3]. Declines from B. salamandrivorans are thought to be 63 
recent and restricted to salamander populations in Northern Europe, although its’ spread to other 64 
geographical regions are predicted to cause additional population declines and extinctions [4, 5]. 65 
Batrachochytrium dendrobatidis, on the other hand, has been causing declines across the whole class 66 
of amphibians on a worldwide scale since the 1970’s [1]. Although there are a number of globally 67 
distributed endemic lineages of B. dendrobatidis that do not appear to cause mass mortality events 68 
within their range, the hypervirulent Global Panzootic Lineage (GPL) continues to cause amphibian 69 
declines and extinctions in the Americas, Australia and Europe [1]. In addition, there is variation in the 70 
virulence of different GPL isolates for a given host species, however little is known about factors that 71 
influence host susceptibility across the genetic and pathogenicity variation exhibited by GPL [6-9]. 72 
Amphibians, like all vertebrates, have evolved a number of defences to protect them from infectious 73 
diseases. Of particular interest are skin-associated products found in the mucus of amphibians, which 74 
form the first line of defence on contact with pathogens such as Batrachochytrium spp. These 75 
products include peptides, lysozymes, alkaloids, antibodies, symbiotic bacteria and bacterial 76 
metabolites, and are collectively known as the ‘mucosome’ [10]. The in vitro anti-B. dendrobatidis 77 
function of the mucosome has been shown to correlate directly with in vivo susceptibility and pathogen 78 
prevalence across a number of amphibian species [10]. It has previously been shown that individual 79 
bacteria isolated from the skin of amphibians show variation in their ability to inhibit across the range 80 
of genetic variation shown by GPL [11-13], but whether this is also true for the mucosome has not yet 81 
been tested. 82 
 83 
Here we determine whether mucosomes collected from two host amphibian species show variation in 84 
their inhibitory capabilities across a suite of eight globally-distributed B. dendrobatidis GPL isolates 85 
(Table 1). Batrachochytrium dendrobatidis isolates were selected that appear in different parts of the 86 
B. dendrobatidis GPL phylogenetic tree (O’Hanlon, pers. comm.) and that represent an international 87 
distribution, including four isolates from South Africa where the frogs used in the study were collected. 88 
Isolates originated from a range of different host species (Table 1) and had been passaged between 7 89 
and 12 times. For this study, eight sub-adult African bullfrogs (Pyxicephalus adspersus) and eight 90 
adult common river frogs (Amietia delalandii) were collected from Potchefstroom, North-West 91 
Province, South Africa and transported individually in sterile plastic bags to the lab, where mucosomes 92 
were immediately collected from each individual according to Woodhams et al. [10]. Briefly, frogs were 93 
placed in individual sterile cups and a given volume of sterile water added to each cup according to 94 
the surface area of each frog. Animals were held in the cups for one hour, after which the mucosome 95 
 4 
rinse water was collected and filtered through a 0.22µm sterile filter (Millipore, Ireland) and kept on ice 96 
until challenge assays were conducted. Mucosomes were challenged against eight B. dendrobatidis 97 
GPL isolates using an in vitro spectrophotometer assay method adapted from Bell et al. [14], 98 
Woodhams et al. [10] and Becker et al. [15]. Three flasks of each Batrachochytrium dendrobatidis 99 
isolate were grown in 1% tryptone broth at 21°C until maximum zoospore production was observed 100 
(~3-4 days; ~1 x 106 zoospores ml-1). The three flasks of each isolate were combined and zoospores 101 
separated from sporangia by filtering through 20µm sterile filters (Millipore, Ireland). To conduct the 102 
spectrophotometer assays, 50µl of mucosome and 50µl of B. dendrobatidis suspension were pipetted 103 
into 96 well plates. Each B. dendrobatidis-mucosome combination was run with six replicates. Positive 104 
controls were included using 50µl sterile water instead of mucosome filtrate. Negative controls were 105 
included using 50µl sterile water and 50µl of heat-treated B. dendrobatidis for each isolate.  106 
 107 
Plate readings were taken every 24 hours for four days using a 492nm filter. Data were transformed 108 
using the equation Ln(OD/(1-OD)), and regression analysis used to gain the slope values for each 109 
sample over time. Total B. dendrobatidis inhibition was calculated using the following formula; 110 
Inhibition (%) = [1-(slope of sample/slope of control)] x 100, where a positive number represents 111 
inhibition of B. dendrobatidis growth and a negative number indicates enhanced growth of B. 112 
dendrobatidis. The average inhibition percentage was calculated for each individual sample, and the 113 
eight samples acted as replicates for a given host species in subsequent analyses. 114 
 115 
Overall, most B. dendrobatidis isolates were inhibited in the presence of mucosomes from both 116 
species (Figure 1). A Mann-Whitney U test indicated significant differences in mucosome inhibition 117 
between the two species for the UK1 isolate of B. dendrobatidis (W = 20, p = 0.015), but there were no 118 
significant differences between host species for all other isolates (all p > 0.05). Almost all B. 119 
dendrobatidis isolates were inhibited when challenged with mucosome from A. delalandii, with the 120 
exception of two isolates that showed negligible growth or inhibition (South Africa 1a and UK2; Figure 121 
1). There were significant differences in A. delalandii mucosome inhibition between B. dendrobatidis 122 
isolates (Kruskall-Wallace chi-squared = 21.686, d.f. = 7, p = 0.003) and a Dunn post-hoc analysis 123 
indicated significant differences between a number of isolates (Table 2). Almost all isolates were 124 
different to 2-4 other isolates, with no discernible relation to geographical origin of isolate. The isolate 125 
from Spain was not statistically different to any other B. dendrobatidis isolate, with intermediate growth 126 
inhibition in comparison to all others (Figure 1; Table 2). As with A. delalandii, the growth of most 127 
isolates of GPL was inhibited when challenged with mucosome collected from P. adspersus, with the 128 
exceptions of South Africa 1b (negligible growth or inhibition), South Africa 3 (high level of variation in 129 
its response) and UK1, which exhibited very high levels of enhanced growth in the presence of P. 130 
adspersus mucosome (Figure 1). The overall model for differences in growth of B. dendrobatidis 131 
isolates in the presence of P. adspersus mucosome was significant (Kruskall-Wallace chi-squared = 132 
21.596, d.f. = 7, p = 0.003). The Dunn pairwise comparisons (Table 2) show that UK1 was significantly 133 
different to all other isolates of GPL with the exception of South Africa 1b, which was significantly 134 
different to the Spain and Sardinia isolates.  135 
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 136 
Together these results show that the growth of different isolates of B. dendrobatidis GPL varies 137 
significantly in the presence of amphibian mucosomes, and that there is some variation in mucosome 138 
inhibition between host species across the range of isolates. This suggests that the response of the 139 
pathogen is linked to traits associated with the host mucosome as well as inherent traits of the various 140 
B. dendrobatidis isolates. It has previously been shown that individual bacteria isolated from 141 
amphibian skin also show variation in their ability to inhibit across a range of B. dendrobatidis isolates 142 
[11-13], suggesting that the bacteria or their metabolites within the mucosome play a role in 143 
determining inhibition of a given isolate of B. dendrobatidis. A number of recent studies show that the 144 
composition of the bacterial community associated with the skin of amphibians is correlated with 145 
infection probability of B. dendrobatidis [16-19]. Although the role of the microbiome composition in 146 
determining susceptibility across GPL variation has not yet been tested in vivo, the in vitro data 147 
presented here along with that of Antwis et al. [11], Muletz et al. [12] and Bletz et al. [13] indicates 148 
strong potential for variation in the response of the host to different isolates of the fungal pathogen, 149 
both in terms of changes in the host microbiome and the infection outcome for the host. Other 150 
mucosome traits aside from bacteria (e.g. peptides, lysozymes) may also account for the variation in 151 
mucosome-pathogen responses in our data. Amphibians show variation in their susceptibility to 152 
different isolates of B. dendrobatidis [6-9], and the data presented here suggest this may be related to 153 
interactions between B. dendrobatidis and some aspect(s) of the mucosome defences of amphibians. 154 
Additionally, this pathogen has a highly complex genome with widespread aneuploidy [5, 24]; the 155 
variation in mucosal inhibition between different B. dendrobatidis isolates demonstrated here may be 156 
linked to differential phenotypic or genotypic traits associated with these isolates as has been 157 
suggested in other studies [6-9].  158 
 159 
Overall, most B. dendrobatidis isolates showed reduced growth in the presence of mucosomes from 160 
both species (Figure 1). Amietia delalandii are not known to be experiencing chytridiomycosis-related 161 
declines in the wild although populations are infected with low levels of B. dendrobatidis (38.8% 162 
prevalence, B. dendrobatidis genomic equivalents < 5.0, n = 464; [23]). Infected wild P. adspersus 163 
have not been found to date (genomic equivalents = 0.0, n = 10; Weldon, unpublished data). The data 164 
presented here suggests the mucosomes of both species may play a role in resisting B. dendrobatidis 165 
infection, although little is known about the defences of these species and there are many other 166 
factors that will also influence susceptibility to B. dendrobatidis. In addition, it is not known if the 167 
individuals used in this study were infected with B. dendrobatidis, which may influence the propensity 168 
of the mucosome to inhibit the pathogen. 169 
 170 
Experimental work may allow for the prediction and/or identification of particular community traits (e.g. 171 
high/low abundance of particular bacterial genera) that confer broad-scale inhibition against the wide 172 
genetic and virulence variation shown by B. dendrobatidis. The current regimes for treating 173 
chytridiomycosis are often laborious and have limited transferability to wild populations [20]. However, 174 
the potential use of probiotics is increasingly being researched [21, 22], and it may be possible to 175 
 6 
exploit mucosome traits linked to broad scale inhibition across the variation presented by B. 176 
dendrobatidis in order to develop robust and effective treatments and/or prophylaxis for 177 
chytridiomycosis in situ. In addition, teasing apart how genomic and transcriptomic factors associated 178 
with Batrachochytrium dendrobatidis interact with hosts and host-associated mucosomes, and how 179 
these factors relate to virulence traits, will provide valuable information about B. dendrobatidis 180 
epidemiology and ultimately, the mitigation of chytridiomycosis in amphibians. 181 
 182 
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Figure 1 302 
Average (± 1 S.E.) inhibition of eight globally distributed isolates of the Global Panzootic Lineage of 303 
Batrachochytrium dendrobatidis by skin mucosomes collected from two South African host amphibian 304 
species. Positive numbers represent inhibition of B. dendrobatidis growth and negative numbers 305 
indicate enhanced growth of B. dendrobatidis. See Table 2 for statistically different pairwise 306 
comparisons. 307 
 308 
 309 
 310 
 311 
Table 1 312 
Batrachochytrium dendrobatidis isolates used in the study. 313 
 314 
Isolate Archive 
code 
Geographical origin Host species isolated 
from 
South Africa 1a MG04 Silver Mine, Western Cape, South 
Africa 
Amietia fuscigula 
South Africa 1b MG06 Silver Mine, Western Cape, South 
Africa 
Amietia fuscigula 
South Africa 2 MG08 Magoebaskloof, Limpopo, South Africa Amietia delalandii 
South Africa 3 MG09 Magoebaskloof, Limpopo, South Africa Hadromophryne natalensis 
UK 1 CORN 3.1 Penhale Farm, Cornwall, UK Ichthyosaurus alpestris 
UK 2 SFBC 014 Sellafield, Cumbria, UK Bufo bufo 
Spain IA 2011 Ibon Acherito, Spain Alytes obstetricans 
Sardinia MODS 28.1 Mont Olia, Sandinia Discoglossus sardus 
 315 
 316 
 317 
 318 
 319 
 320 
 321 
 322 
 323 
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 324 
Table 2 325 
Dunn pairwise comparisons between Batrachochytrium dendrobatidis isolate growth in the presence 326 
of Amietia delalandii (green) and Pyxicephalus adspersus (orange) mucosomes. Results in bold and 327 
with an * indicate a statistically significant result. 328 
 329 
 
South 
Africa 1a 
South 
Africa 1b 
South 
Africa 2 
South Africa 
3 
UK1 
 
UK2 
 
Spain 
 
Sardinia 
 
South 
Africa 
1a 
 
 p=0.412 p=0.033* p=0.021* p=0.037* p=0.444 p=0.168 p=0.038* 
South 
Africa 
1b 
 
p=0.131  p=0.067 p=0.038* p=0.069 p=0.347 p=0.262 p=0.073 
South 
Africa 2 
 
p=0.474 p=0.134  p=0.378 p=0.488 p=0.037* p=0.240 p=0.495 
South 
Africa 3 
 
p=0.468 p=0.132 p=0.478  p=0.405 p=0.017* p=0.112 p=0.378 
UK1 
 
p=0.016* p=0.216 p=0.016* p=0.020*  p=0.029* p=0.252 p=0.476 
UK2 
 
p=0.494 p=0.161 p=0.483 p=0.462 p=0.020*  p=0.109 p=0.030* 
Spain 
 
p=0.384 p=0.044* p=0.373 p=0.434 p=0.007* p=0.351  p=0.240 
Sardinia 
 
p=0.213 p=0.018* p=0.205 p=0.251 p=0.001* p=0.175 p=0.382  
 330 
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